HomeGLUE • NASDAQ
Monte Rosa Therapeutics Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 60.65M | — |
Operating expense | 10.88M | 15.83% |
Net income | 13.44M | 140.41% |
Net profit margin | 22.16 | — |
Earnings per share | 0.27 | 146.55% |
EBITDA | 15.07M | 145.63% |
Effective tax rate | 13.87% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 372.15M | 60.12% |
Total assets | 438.73M | 44.44% |
Total liabilities | 215.80M | 73.32% |
Total equity | 222.94M | — |
Shares outstanding | 61.51M | — |
Price to book | 1.12 | — |
Return on assets | 8.63% | — |
Return on capital | 12.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 13.44M | 140.41% |
Cash from operations | 128.92M | 335.05% |
Cash from investing | -30.90M | -316.10% |
Cash from financing | 608.00K | -97.58% |
Net change in cash | 98.63M | 42.73% |
Free cash flow | 133.94M | 1,847.21% |
Previous close
$4.06
Day range
$3.93 - $4.32
Year range
$3.21 - $12.40
Market cap
243.28M USD
Avg Volume
771.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
134
